Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Daiichi Arbitration Case Bares Trail Of Deception At Ranbaxy

Executive Summary

Incriminating details in an arbitration order against the former Ranbaxy top brass led by the Singh brothers has put the spotlight back on allegations of misrepresentation of critical information concerning the US Department of Justice (DoJ) and FDA investigations against the Indian company at the time of its takeover by Daiichi Sankyo. The Singh brothers, who have challenged the award, though, have cried foul, questioning the timing of the apparent leak of the "confidential" award ahead of a court hearing.


Related Content

Sun Faces Price Pressures In US On Generic Gleevec
Golden Week For Daiichi: Damages Due From Ranbaxy Brothers
Sun Rationalization Underway; To Shed Irish Facility
Daiichi set for $3.6bn cash out of Sun
India's turnaround specialist Sun snaps Ranbaxy in $4bn deal
Blowing The Whistle On Ranbaxy
Ranbaxy whistleblower pockets $50M+ in $500M settlement


Related Companies